Deborah Ashton
Overview
Explore the profile of Deborah Ashton including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
184
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lansbury L, McKeever T, Lawrence H, Pick H, Baskaran V, Edwards-Pritchard R, et al.
Thorax
. 2024 Dec;
80(2):86-96.
PMID: 39667904
Background: With higher valency pneumococcal vaccines on the horizon and new adult immunisation strategies under discussion, we aimed to evaluate the contribution of individual pneumococcal serotypes to the burden of...
2.
Lansbury L, McKeever T, Lawrence H, Pick H, Baskaran V, Edwards-Pritchard R, et al.
J Infect
. 2024 Sep;
89(5):106277.
PMID: 39306250
Objectives: We aimed to determine the prevalence of and risk factors for nasopharyngeal and oral pneumococcal carriage in adults with community-acquired pneumonia (CAP), and the relationship between carried and disease-causing...
3.
Lansbury L, Lawrence H, McKeever T, French N, Aston S, Hill A, et al.
Lancet Reg Health Eur
. 2024 Jan;
37:100812.
PMID: 38170136
Background: Higher-valency pneumococcal vaccines are anticipated. We aimed to describe serotype distribution and risk factors for vaccine-serotype community-acquired pneumonia (CAP) in the two years pre-SARS-CoV-2 pandemic. Methods: We conducted a...
4.
Pick H, Faghy M, Creswell G, Ashton D, Bolton C, McKeever T, et al.
Adv Respir Med
. 2021 Apr;
89(2):216-220.
PMID: 33881155
Introduction: Patients experience substantial morbidity following discharge from hospital and during recovery from communi-ty-acquired pneumonia (CAP). Inspiratory muscle training (IMT) has demonstrated improved functional capacity and reduced patient-reported symptoms. To...
5.
Lawrence H, Pick H, Baskaran V, Daniel P, Rodrigo C, Ashton D, et al.
PLoS Med
. 2020 Oct;
17(10):e1003326.
PMID: 33095759
Background: Vaccination with the 23-valent pneumococcal polysaccharide vaccine (PPV23) is available in the United Kingdom to adults aged 65 years or older and those in defined clinical risk groups. We...
6.
Pick H, Daniel P, Rodrigo C, Bewick T, Ashton D, Lawrence H, et al.
Thorax
. 2019 Oct;
75(1):38-49.
PMID: 31594801
Background: Changes over the last 5 years (2013-18) in the serotypes implicated in adult pneumococcal pneumonia and the patient groups associated with vaccine-type disease are largely unknown. Methods: We conducted...
7.
Doherty M, Jenkins W, Richardson H, Sarmanova A, Abhishek A, Ashton D, et al.
Lancet
. 2018 Oct;
392(10156):1403-1412.
PMID: 30343856
Background: In the UK, gout management is suboptimum, with only 40% of patients receiving urate-lowering therapy, usually without titration to achieve a target serum urate concentration. Nurses successfully manage many...
8.
Daniel P, Bewick T, McKeever T, Roberts M, Ashton D, Smith D, et al.
Clin Med (Lond)
. 2018 Feb;
18(1):41-46.
PMID: 29436438
Community-acquired pneumonia (CAP) is associated with prolonged symptom persistence during recovery. However, the effect of the residual symptom load on healthcare utilisation is unknown. The aim of this study was...
9.